TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas.
Saved in:
| Title: | TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas. |
|---|---|
| Authors: | Zhang Y; Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX, United States., Barkdull S; Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX, United States., Kontoyiannis PD; McGovern Medical School, University of Texas Health Science Center, Houston, TX, United States., Legarreta AF; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States., Gershenson DM; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States., Ramalingam P; Department of Anatomical Pathology, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States., Frumovitz MM; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Aug 14; Vol. 15, pp. 1573801. Date of Electronic Publication: 2025 Aug 14 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40896434 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Barkdull+S%22">Barkdull S</searchLink>; Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Kontoyiannis+PD%22">Kontoyiannis PD</searchLink>; McGovern Medical School, University of Texas Health Science Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Legarreta+AF%22">Legarreta AF</searchLink>; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Gershenson+DM%22">Gershenson DM</searchLink>; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ramalingam+P%22">Ramalingam P</searchLink>; Department of Anatomical Pathology, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Frumovitz+MM%22">Frumovitz MM</searchLink>; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Sood+AK%22">Sood AK</searchLink>; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas Medical Doctor (MD) Anderson Cancer Center, Houston, TX, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Aug 14; Vol. 15, pp. 1573801. <i>Date of Electronic Publication: </i>2025 Aug 14 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40896434 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1573801 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1573801 Titles: – TitleFull: TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Barkdull S – PersonEntity: Name: NameFull: Kontoyiannis PD – PersonEntity: Name: NameFull: Legarreta AF – PersonEntity: Name: NameFull: Gershenson DM – PersonEntity: Name: NameFull: Ramalingam P – PersonEntity: Name: NameFull: Frumovitz MM – PersonEntity: Name: NameFull: Sood AK IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 08 Text: 2025 Aug 14 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
